Kinesiological / Dietary Supplement Intervention in Knee Osteoarthritis

NCT ID: NCT06269549

Last Updated: 2025-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

93 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-11

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to assess the effectiveness of dietary supplement combined with exercise in managing knee osteoarthritis (KOA). The main questions it aims to answer are:

* Is adding a dietary supplement to exercise additionally effective in managing KOA?
* Is adding exercise to the dietary supplement additionally effective in managing KOA?

Participants will be given in three groups:

1. Real dietary supplement alone
2. Real dietary supplement with exercise
3. Placebo dietary supplement with exercise

Investigators will compare groups 1 and 2, or 2 and 3, to answer the research questions.

The hypothesis is that participants who receive the dietary supplement along with exercise will experience greater reduction in pain level, improved physical function, and enhanced quality of life compared to those who receive a placebo combined with exercise or dietary supplement alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participant recruitment will take place at the Community Healthcare Center dr. Adolf Drolc Maribor based on the doctor's recommendation. Following an informed discussion about the study and potential risks, all patients providing written consent will undergo a one-week screening period to determine eligibility for study entry. Upon reaching week 0, patients meeting the eligibility criteria will be randomly assigned in a 1:1:1 ratio to receive either dietary supplements alone, dietary supplements combined with exercise, or placebo dietary supplement combined with exercise.

The effects of the kinesiological / dietary supplement intervention on selected measures will be assessed using a test battery, before and after the 12 week intervention, and at a 6-week follow-up.

Exercise / test batery will be conducted at Community Healthcare Center dr. Adolf Drolc under the supervision of an experienced kinesiologist / investigator.

Based on the posed research questions and hypotheses, investigators would like to highlight the following planned statistical analyses. In the case of bilateral KOA, investigators will analyze the more affected knee for differences between groups. In addition to descriptive statistics, investigators will assess normal distribution and homogeneity of variances. Differences between groups will be tested using two-way repeated measures analysis of variance (factor 1 = group, factor 2 = time) and paired two-tailed post-hoc t-tests with Bonferroni correction. The main comparison will be addressed with a 2x2 two-way analysis of variance. The first research question will be addressed with a 2x2 two-way analysis of variance, including groups 2 and 3. The second research question will be addressed with a two-way analysis of variance, including groups 1 and 2. Additionally, effect size will be calculated. The level of statistical significance will be set at p\<0.05.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis, Knee

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

The differences between groups will be tested using a two-way analysis of variance for repeated measures (factor 1 = group, factor 2 = time)
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators
Placebo blinding / masked for dietary supplement

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The effect of dietary supplements added to physical exercise intervention

This study arm will include two groups of participants, one receiving 12 weeks physical exercise intervention together with real dietary supplements (glucosamne and collagen), while the other group receiving exercise intervention with placebo dietary supplements (placebo glucosamine and collagen).

Group Type OTHER

Training Placebo Dietary Supplement (G2)

Intervention Type OTHER

One capsule of placebo glucosamine three times daily, and one packet containing placebo collagen + physical exercise (60 minutes per session twice a week)

Training Real Dietary Supplement (G3)

Intervention Type OTHER

One capsule of glucosamine three times daily, and one packet of hydrolyzed collagen + physical exercise (60 minutes per session twice a week)

The effect of physical exercise added to dietary supplement intervention

This study arm will include two groups of participants, one receiving 12 weeks real dietary supplements alone (glucosamine and collagen), while the other group receiving real dietary supplements (glucosamine and collagen) with physical exercise.

Group Type OTHER

Non-training Real Dietary Supplement (G1)

Intervention Type OTHER

One capsule of glucosamine three times daily, and one packet of hydrolyzed collagen.

Training Real Dietary Supplement (G3)

Intervention Type OTHER

One capsule of glucosamine three times daily, and one packet of hydrolyzed collagen + physical exercise (60 minutes per session twice a week)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-training Real Dietary Supplement (G1)

One capsule of glucosamine three times daily, and one packet of hydrolyzed collagen.

Intervention Type OTHER

Training Placebo Dietary Supplement (G2)

One capsule of placebo glucosamine three times daily, and one packet containing placebo collagen + physical exercise (60 minutes per session twice a week)

Intervention Type OTHER

Training Real Dietary Supplement (G3)

One capsule of glucosamine three times daily, and one packet of hydrolyzed collagen + physical exercise (60 minutes per session twice a week)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* knee osteoarthritis of one or both knee
* severity of knee osteoarthritis based on Kellgren-Lawrence radiographic grade 1-3
* knee pain between 4 and 7 (using a 0-10 scale)

Exclusion Criteria

* Age \<55 years
* Kellgren \& Lawrence grade 4 of knee osteoarthritis
* Acute knee injuries within the last 6 months
* Knee pain not associated with knee osteoarthritis
* History of knee or hip endoprosthesis
* Surgery on the back, hip, knee, ankle, or foot within the last 12 months
* Health issues or musculoskeletal limitations affecting strength training and mobility more than knee pain (e.g., lower back pain, hip pain)
* Rheumatoid arthritis, gout
* Neurological conditions (Alzheimer's disease, Parkinson's disease, metabolic diseases affecting the nervous system)
* Muscular or joint diseases/injuries affecting lower limb function (e.g., hip and/or ankle osteoarthritis, sprains, fractures)
* Internal medical conditions (cardiovascular, pulmonary, oncological, diabetes with late complications - diabetic foot, neuropathies) affecting physical performance
* Stroke or similar condition with consequences on motor skills and/or cognition (inability to provide consent)
* Balance disorders, known vestibular system impairment
* Body Mass Index \> 32
* Structured strength training exceeding 30 minutes per week
* Corticosteroids and/or hyaluronic acid (intra-articular) use in the last 6 months
* Individuals taking joint health dietary supplements, like glucosamine, chondroitin, or collagen, will need to halt use for at least 30 days before measurements to avoid affecting study outcomes
Minimum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Community Healthcare Center dr. Adolf Drolc Maribor (HCM)

OTHER

Sponsor Role collaborator

University of Primorska

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nejc Sarabon

Full Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nejc Šarabon, PhD

Role: STUDY_CHAIR

University of Primorska, Faculty of Health Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Primorska, Faculty of Health Sciences

Izola, , Slovenia

Site Status RECRUITING

Community Healthcare Center dr. Adolf Drolc

Maribor, , Slovenia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Slovenia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nejc Šarabon, PhD

Role: CONTACT

05 662 64 66 ext. +386

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nejc Šarabon, PhD

Role: primary

05 662 64 66 ext. +386

Jernej Završnik, PhD

Role: primary

02 2286 257 ext. +386

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KDS_KOA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Aquamin F on Osteoarthritis of the Knee
NCT00452101 COMPLETED PHASE1/PHASE2